[ad_2]
NEW YORK, Aug. 23, 2023 /PRNewswire/ — The compounding pharmacy market size is estimated to grow by USD 1,682.04 million from 2022 to 2027. The market is estimated to accelerate at a CAGR of 2.18%, according to Technavio. Download a Sample Report Now!
Compounding Pharmacy Market Insights –
- Companies: 15+, Including, ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC, among others
- Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and companies landscape; company product insights and recent developments; key companies; and market positioning of companies
- Segments: Product (Topical medications, Oral medications, Parenteral medications, and Other medications), therapeutic area (pain management, hormone replacement, dermal disorders, and other therapeutic areas), and Geography (North America, Europe, Asia, and Rest of World (ROW))
To understand more about the compounding pharmacy market, request a sample report
Compounding Pharmacy Market – Company Insights
The growing competition in the market is compelling companies to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market’s competitive landscape and offers information on several market companies including ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC, among others.
Compounding Pharmacy Market – Market Dynamics
Major Drivers –
The increasing popularity of HRT fueling demand for compounded medications drives the market growth during the forecast period. There is increasing popularity for compounded hormonal replacement therapy (HRT) medications due to the availability of active pharmaceutical ingredients (APIs) in different dosages. Additionally, there has been a rising demand for personalized HRTs due to the increasing awareness of critical health issues including mood swings, hot flashes, acute depression, osteoporosis, breast and bone health, and erectile longevity. Furthermore, there is a rising demand for hormones including progesterone after hysterectomy, testosterone replacement, and hormones that cure infertility has increased due to dosage needs for unique personalized solutions. Hence, such factors are positively impacting the market which in turn drives the market growth during the forecast period.
Significant Trends-
The growing popularity of personalized medicines is a primary trend in the market during the forecast period.
Key Challenges –
The unsafe usage of compounded drugs is a major challenge hindering the market growth during the forecast period.
The compounding pharmacy market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
Why Buy?
- Add credibility to strategy
- Analyzes competitor’s offerings
- Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Compounding Pharmacy Market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the compounding pharmacy market between 2023 and 2027
- Precise estimation of the compounding pharmacy market size and its contribution to the market with a focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the compounding pharmacy market across North America, Europe, Asia, and the Rest of the World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of compounding pharmacy market players.
Gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Related Reports:
The thyroid gland disorder treatment market size is estimated to grow by USD 868.87 million at a CAGR of 5.33% between 2022 and 2027. The market has segmented the market into type ( hypothyroidism and hyperthyroidism), distribution channel (offline and online), and geography segments(North America, Europe, Asia, and the Rest of the World (ROW)). Increasing demand for levothyroxine is a major factor driving the market growth.
The flow diversion aneurysm treatment market size is estimated to grow by USD 2,107.08 million at a CAGR of 8.8% between 2022 and 2027. The market is segmented into product (FDS and intravascular flow disruption devices), end-user( hospitals and specialty clinics), and geography(North America, Europe, Asia, and the Rest of the World (ROW)). The increasing Incidence of intracranial aneurysms is a growing driver in flow diversion aneurysms.
Compounding Pharmacy Market Scope | |
Report Coverage | Details |
Base year | 2022 |
Historic period | 2017-2021 |
Forecast period | 2023-2027 |
Growth momentum & CAGR | Accelerate at a CAGR of 2.18% |
Market growth 2023-2027 | USD 1,682.04 million |
Market structure | Fragmented |
YoY growth 2022-2023 (%) | 1.9 |
Regional analysis | North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution | Asia at 37% |
Key countries | US, Canada, France, China, and Japan |
Competitive landscape | Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled | ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC |
Market dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Historic Market Size
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by Therapeutic Area
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/compounding-pharmacy-market-to-grow-by-usd-1-68-billion-from-2022-to-2027–growing-popularity-of-hrt-fueling-demand-for-compounded-medications-boosts-the-market-growth—technavio-301906627.html
SOURCE Technavio
Source link
[ad_2]
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
[ad_2]
